Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,950 shares of the medical equipment provider’s stock after purchasing an additional 33 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Zimmer Biomet Holdings were worth $1,920,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of ZBH. Enterprise Financial Services Corp increased its stake in shares of Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after buying an additional 9 shares in the last quarter. Sandy Spring Bank grew its holdings in Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after acquiring an additional 20 shares during the period. Parkside Financial Bank & Trust boosted its position in shares of Zimmer Biomet Holdings by 2.7% in the 1st quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after purchasing an additional 22 shares during the last quarter. Cleararc Capital Inc. lifted its stake in Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after buying an additional 25 shares during the period. Finally, Palladium Partners LLC increased its stake in shares of Zimmer Biomet Holdings by 1.7% in the 2nd quarter. Palladium Partners LLC now owns 2,501 shares of the medical equipment provider’s stock valued at $321,000 after acquiring an additional 41 shares during the last quarter. Institutional investors own 85.35% of the company’s stock.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) opened at 114.40 on Friday. Zimmer Biomet Holdings, Inc. has a 12-month low of $95.63 and a 12-month high of $133.49. The firm has a 50-day moving average price of $114.50 and a 200-day moving average price of $120.75. The company has a market cap of $23.13 billion, a P/E ratio of 32.58 and a beta of 1.21.
Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.10 by ($0.02). The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.02 earnings per share. On average, equities research analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 22nd will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.84%. The ex-dividend date of this dividend is Thursday, September 21st. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.
COPYRIGHT VIOLATION WARNING: This article was originally posted by BBNS and is owned by of BBNS. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://baseballnewssource.com/markets/commonwealth-of-pennsylvania-public-school-empls-retrmt-sys-purchases-33-shares-of-zimmer-biomet-holdings-inc-zbh/1603697.html.
In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.07% of the stock is owned by company insiders.
A number of analysts have commented on the stock. Royal Bank Of Canada reiterated an “outperform” rating and issued a $140.00 price target on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Wells Fargo & Company reaffirmed a “market weight” rating on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Jefferies Group LLC reissued a “buy” rating and issued a $148.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, June 30th. Piper Jaffray Companies reiterated a “buy” rating and set a $135.00 target price on shares of Zimmer Biomet Holdings in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $137.00 price target on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Friday, July 28th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $136.58.
Zimmer Biomet Holdings Company Profile
Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.
Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with our FREE daily email newsletter.